Back to Screener

Consumer Defensive

RiceBran Technologies(RIBT)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+0.00%

Window

Jun 20, 2025 โ†’ Jun 12, 2026

Market Cap
โ€”
Revenue Growth
-15.0%
EPS Growth
+9.9%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 20, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

RiceBran Technologies (RIBT) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of -15.0%, EPS growth of +9.9%, a dividend yield of 0.0%. What stands out right now is revenue -15.0%, EPS +9.9%, free cash flow +30.9% with operating margin -28.1% and ROIC -247.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RIBT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-15.0% vs +1.7% peer median

Operating Margin

Below sector median

-28.1% vs +6.6% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

The operating picture looks softer than before

Revenue is at -15.0% and EPS is at +9.9%, with operating margin around -28.1%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

RIBT

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

RIBT Max Drawdown

-66.67%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for RIBT and SPY.

Calendar-year return history is still loading or unavailable.
RiceBran Technologies logo

Company Overview

RiceBran Technologies

Other OTC

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

Leadership
Eric Tompkins
IPO Date
Oct 1, 2003
Employees
35
Street Address
25420 Kuykendahl Road
Mailing
Tomball, TX, 77375
Region
Tomball, TX, US
Reporting Currency
USD
Investor Line
281 675 2421
Last Updated
May 4, 2026
CIK: 0001063537ISIN: US7628313030CUSIP: 762831204
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
0.0
Price/Book
โ€”

Growth

Revenue
-15.0%
EPS
+9.9%
Free Cash Flow
+30.9%

Profitability

Gross Margin
-1.8%
Operating Margin
-28.1%
Net Margin
-39.6%
ROE
-181.1%
ROIC
-247.1%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.54

Earnings Reports

No earnings data available

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.